Biolife Solutions (BLFS) Enterprise Value (2010 - 2026)

Biolife Solutions (BLFS) has reported Enterprise Value for 17 consecutive years, with $1.3 billion the latest figure, recorded in Q2 2026.

• On a quarterly basis, Enterprise Value rose 36.82% year-over-year to $1.3 billion in Q2 2026; TTM through Jun 2026 was $1.3 billion, a 36.82% increase from a year earlier, with the FY2025 full-year figure at $1.1 billion, down 3.62% from the prior year.
• Enterprise Value was $1.3 billion for Q2 2026 at Biolife Solutions, up from $850.6 million in the prior quarter.
• Over five years, Enterprise Value peaked at $1.3 billion in Q2 2026 and troughed at $540.9 million in Q2 2022.
• A 5-year average of $913.2 million and a median of $911.9 million in 2022 frame the typical range for Enterprise Value.
• Across the five-year window, Enterprise Value sank 68.72% in 2022 and soared 99.08% in 2024, its largest moves.
• Over 5 years, Enterprise Value stood at $716.8 million in 2022, then fell by 3.78% to $689.8 million in 2023, then jumped by 61.93% to $1.1 billion in 2024, then declined by 3.62% to $1.1 billion in 2025, then climbed by 20.59% to $1.3 billion in 2026.
• The last three Enterprise Value figures came in at $1.3 billion (Q2 2026), $850.6 million (Q1 2026), and $1.1 billion (Q4 2025), per Business Quant data.